Catherine Labinjoh

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

Matthew M.Y. Lee, Katriona Brooksbank, Kirsty Wetherall et al. · Circulation · 2020 · 437 citations · Full text

Medicine, Cardiology, Pharmacology +17

Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking

David E. Newby, Robert A. Wright, Catherine Labinjoh et al. · Circulation · 1999 · 381 citations · Full text

Medicine, Cardiology, Pharmacology +15

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 372 citations · Full text

Medicine, Cardiology, Internal Medicine +11

Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition

Catherine Labinjoh, David E. Newby, M.Paola Pellegrini et al. · Journal of the American College of Cardiology · 2001 · 46 citations

Life Sciences, Pharmacology, Cell Signaling +11

Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man

Catherine Labinjoh · Cardiovascular Research · 2000 · 41 citations

Medicine, Pharmacology, Physiology +14